Lapatinib Completed Phase 2 Trials for Malignant Neoplasm of Pancreas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00962312Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer